• If you are wondering whether Healthpeak Properties at US$20.03 is priced attractively or not, the starting point is understanding what the current market is implying about its value.
• The stock has returned 3.8% over the last 7 days, 21.9% over the past month and 23.6% year to date, with a 1 year return of 23.8% and a 3 year return of 21.4%, while the 5 year period shows a decline of 22.8%.
• Recent coverage around Healthpeak Properties has focused on its role within the Health Care REITs space and how investor expectations are being reflected in the share price. This context helps explain why shorter term returns have differed from the longer term picture.
• On Simply Wall St’s 6 point valuation checklist, Healthpeak Properties currently scores 2 out of 6. The next sections will compare common valuation approaches, and a final section will point to an even more complete way to think about what the stock could be worth.

Healthpeak Properties scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Healthpeak Properties Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes Healthpeak Properties’ adjusted funds from operations, projects them into the future, and then discounts those cash flows back to today using a required rate of return. This gives an estimate of what the stock could be worth based purely on projected cash generation.

For Healthpeak Properties, the latest twelve months free cash flow is about $1.29b. Analyst and extrapolated projections used in this model suggest free cash flow of around $1.51b by 2035, with interim years such as 2026 and 2030 projected at $1.12b and $1.26b respectively. Simply Wall St uses a 2 Stage Free Cash Flow to Equity model based on these adjusted funds from operations, combining analyst estimates where available and extending them further out using its own assumptions.

On this basis, the DCF model arrives at an estimated intrinsic value of $33.12 per share, compared with the current share price of $20.03. This implies the stock is trading at a 39.5% discount to the model’s estimate of fair value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Healthpeak Properties is undervalued by 39.5%. Track this in your watchlist or portfolio, or discover 46 more high quality undervalued stocks.

Approach 2: Healthpeak Properties Price vs Earnings

For profitable companies, the P/E ratio is a useful cross check because it links what you pay for the stock directly to the earnings it generates per share. It also gives a quick sense of how much investors are currently willing to pay for those earnings.

In general, higher growth expectations and lower perceived risk go with a higher “normal” or “fair” P/E ratio, while slower expected growth or higher risk go with a lower one. Healthpeak Properties currently trades on a P/E of 62.31x. This sits above the Health Care REITs industry average P/E of 21.88x and above the peer group average of 43.58x.

Simply Wall St’s Fair Ratio for Healthpeak Properties is 28.65x. This is a proprietary estimate of what the P/E could be given factors such as earnings growth, industry, profit margins, market cap and company specific risks. Because it blends these company characteristics rather than just copying what peers trade on, the Fair Ratio can offer a more tailored yardstick than raw industry or peer comparisons. With the current P/E of 62.31x versus a Fair Ratio of 28.65x, the stock screens as overvalued on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Healthpeak Properties Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so here is Narratives, which let you set out your view of Healthpeak Properties in a simple story that connects your assumptions for future revenue, earnings and margins to a Fair Value that you can then compare with today’s price.

A Narrative links the company’s story to a financial forecast and then to a Fair Value estimate. On Simply Wall St this is done in an accessible tool on the Community page that is used by millions of investors.

Once a Narrative is set up, it helps you decide whether you see Healthpeak Properties as attractively or expensively priced by comparing your Fair Value to the current share price. It then updates automatically when new information such as earnings announcements or news is added to the platform.

For example, one Healthpeak Properties Narrative on Simply Wall St assumes a Fair Value of US$16.00 based on declining revenue and lower margins, while another assumes a Fair Value of US$25.80 with revenue growth and higher margins, and a third sits in the middle at about US$20.17. Your own Narrative makes it clear where you sit on that spectrum and how that translates into your view of the stock.

For Healthpeak Properties, here are previews of two leading Healthpeak Properties narratives:

Fair Value: US$25.80

Implied discount vs current price: about 22.4% below this fair value

Revenue growth assumption: 4.79% a year

• Emphasises AI driven property management and operational upgrades that are expected to lift efficiency, tenant retention and margins compared to current estimates.
• Sees long term support from senior housing exposure, high occupancy potential and positioning in markets tied to an aging US population.
• Builds a higher fair value on assumptions of rising margins and earnings by 2029 while highlighting interest rate, telehealth and tenant concentration risks as key things to watch.

Fair Value: US$16.00

Implied premium vs current price: about 25.2% above this fair value

Revenue growth assumption: revenue is assumed to decline 7.85% a year

• Focuses on tenant risk in life science assets, with smaller biotech tenants reliant on capital markets and vulnerable to occupancy and rent pressure.
• Flags concentration in a few markets, development execution risk and higher refinancing costs as potential drags on cash flow and earnings.
• Arrives at a lower fair value by combining falling revenue and margin assumptions with a higher required P/E multiple, while pointing to buybacks and raised guidance as possible offsets in the short term.

If you want to see how your own expectations compare with these bull and bear setups, it may be useful to read the full narratives behind each view and then stress test them against your own assumptions.

Do you think there's more to the story for Healthpeak Properties? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.